Jingdong Rao

879 citations
21 papers · 735 indexed · h-index 15
Topics
Nanoplatforms for cancer theranostics (10 papers)Nanoparticle-Based Drug Delivery (6 papers)RNA Interference and Gene Delivery (5 papers)
Journals
SHILAP Revista de lepidopterologíaBiomaterialsAdvanced Drug Delivery Reviews
Partner nations
ChinaHong KongCanada

In The Last Decade

Jingdong Rao

21 papers receiving 725 citations

Peers

Jingdong Rao
Comparison fields: 5 of 77
  • Biomedical Engineering 425
  • Biomaterials 278
  • Molecular Biology 237
  • Immunology 141
  • Oncology 89
Replace Xiaoqing Ren with:
Xiaoqing Ren China
Jessica D. Weaver United States
Isaac M. Adjei United States
Zhisheng Xiao China
Honghui Wu China
Yan Wei China
Yazhou Wang China
Gijung Kwak South Korea
Ziying Fei China
Zimiao Luo China
Jingdong Rao relative to Xiaoqing Ren China Xiaoqing Ren's profile →
Citations per field
00.5×
Xiaoqing Ren · 1×
Citations per year

Countries citing papers authored by Jingdong Rao

Since Specialization
Citations

This map shows the geographic impact of Jingdong Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingdong Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingdong Rao more than expected).

Fields of papers citing papers by Jingdong Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingdong Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingdong Rao. The network helps show where Jingdong Rao may publish in the future.

Co-authorship network of co-authors of Jingdong Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingdong Rao. A scholar is included among the top collaborators of Jingdong Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingdong Rao. Jingdong Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 2
3 5
4 37
5 26
6 11
7 72
8 25
9 8
10 62
11 36
12 12
13 24
14 48
15 42
16 26
17 50
18 43
19 55
20 51

About Jingdong Rao

Jingdong Rao is a scholar working on Biomaterials, Biomedical Engineering and Internal Medicine, having authored 21 papers that have together received 735 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (6 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Biomaterials (278 citations), Biomedical Engineering (425 citations) and Immunology (141 citations). Jingdong Rao has collaborated with scholars based in China, Hong Kong and Canada. Frequent co-authors include Qin He, Man Li, Zhirong Zhang, Xin Zhao, Xian Tang, Ling Mei, Ho Pan Bei, Sheng Yin, Chunyu Xia and Yuhe Yang. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Drug Delivery Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026